AmerisourceBergen has announced plans to buy drug compounding firm PharMEDium Healthcare Holdings from private equity group, Clayton, Dubilier & Rice.
Evotec has been hired to manage candidate drug compounds by the US National Cancer Institute (NCI) under an agreement the CRO hopes will help it win further contracts.
BASF expects to reduce its workforce though natural employee turnover rather than redundancies as part of a new €1bn cost cutting plan.
Got experience in endocrinology and metabolism indications R&D? Chiltern has added a new offering and says it is looking to hire.
Siegfried Holdings has completed the takeover of BASF CEO Kurt Brock called the firm’s “relatively successful” pharma business.
Buying an API plant from its supplier Acacia Lifesciences proved more advantageous than building a new facility, says Indian drugmaker Biocon.